— Know what they know.
Not Investment Advice

BNN.DE XETRA

BRAIN Biotech AG
1W: +3.6% 1M: +8.2% 3M: +1.8% YTD: +26.8% 1Y: +31.4% 3Y: -35.8% 5Y: -72.1%
€2.89 ($3.24)
+0.04 (+1.40%)
 
Weekly Expected Move ±7.5%
€2 €3 €3 €3 €3
XETRA · Healthcare · Biotechnology · Tech Score Buy · Power 67 · €63.1M mcap · 10M float · 0.040% daily turnover

Balance Sheet Trends

Total Assets
$66M -25.2% ▼
5Y CAGR: -1.7%
Total Liabilities
$64M -13.8% ▼
5Y CAGR: +7.0%
Shareholders Equity
$2M -85.4% ▼
5Y CAGR: -38.4%
Cash & Investments
$6M -76.9% ▼
5Y CAGR: -19.8%
Total Debt
$24M -19.4% ▼
5Y CAGR: -4.7%
Net Debt
$18M +572.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$25M$8M$5M$27M$6M
Short-Term Investments$55K$82K$55K$58K$126K
Cash & ST Investments$25M$9M$5M$27M$6M
Net Receivables$7M$11M$10M$8M$9M
Inventory$7M$10M$10M$9M$9M
Other Current Assets$183K$559K$356K$1M$108K
Total Current Assets$39M$30M$25M$46M$25M
Property, Plant & Equip.$24M$29M$29M$28M$28M
Goodwill & Intangibles$14M$17M$15M$14M$12M
Long-Term Investments$715K$2M$1M$971K$1M
Other Non-Current Assets$86K$53K$125K$66K$55K
Total Non-Current Assets$39M$48M$45M$43M$41M
Total Assets$78M$78M$71M$89M$66M
— Liabilities —
Accounts Payable$4M$7M$6M$6M$4M
Short-Term Debt$1M$1M$3M$7M$4M
Deferred Revenue$4M$2M$3M$0$6M
Other Current Liabilities$14K$7M$657K$11M$2M
Total Current Liabilities$11M$21M$17M$25M$18M
Long-Term Debt$3M$3M$14M$15M$13M
Other Non-Current Liab.$3M$6M$6M$24M$23M
Total Non-Current Liabilities$25M$22M$30M$50M$47M
Total Liabilities$36M$44M$48M$75M$64M
— Equity —
Common Stock$22M$22M$22M$22M$22M
Retained Earnings-$80M-$85M-$94M-$105M-$116M
Accumulated OCI$555K$328K$628K$1M$295K
Total Stockholders Equity$39M$30M$22M$13M$2M
Total Liabilities & Equity$78M$78M$71M$89M$66M
— Key Metrics —
Total Debt$3M$11M$25M$30M$24M
Net Debt-$22M-$5M-$693K$3M$18M
Total Investments$770K$2M$1M$1M$1M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms